SlideShare a Scribd company logo
1 of 2
86 Taman Nakhoda
Villa Delle Rose
Singapore 257786
21st
October 2015
To Whom It May Concern
Re: Testimonial – Bruce Ratcliffe
It was my pleasure to work with Bruce Ratcliffe when he was Regional Therapy Area
Group Director for Metabolic, Cardiovascular and Urology at GlaxoSmithkline. At the
time, I was Head of Healthcare Research for TNS in APAC. In his role, Bruce set up
a Regional Diabetes Hub, a cross-functional team including GSK personnel from
different disciplines as well as agency representatives from research, PR and
communications. This Hub met for 2-3 days, quarterly, and ensured that his agencies
were fully informed of the business challenges that GSK were facing and were
empowered to recommend activities to create positive change. It also meant that
GSK team members were so involved in the insight and communications process that
they were able to affect it, ensuring internal buy-in into any outputs that were
generated.
I first became involved in the Regional Diabetes Hub when Bruce presented TNS with
a challenge. After 5 years on the market, GSK’s leading Diabetes brand had still not
established itself as the Gold Standard and the Company needed insight into why
and what they could do to take the brand to the next level. TNS proposed an
innovative methodology involving duos with Specialists, and incorporating a variety of
project techniques rarely used in APAC in Healthcare. To Bruce’s credit, he took a
risk, recognized the need for an innovative approach and commissioned this
groundbreaking research. The ‘killer insights’ that resulted formed the basis for the
brand’s sales and marketing initiatives for the next 2 years. In particular, it allowed
Bruce to implement Belief Mapping. This involved a process whereby physicians’
current beliefs were understood in depth, through insights research. We then
identified the beliefs that we wanted them to hold for GSK’s diabetes portfolio to be
successful. And finally, we mapped how to shift their beliefs through a series of steps
and initiatives. Bruce championed this approach regionally, the first time that it had
been implemented in APAC to my knowledge, and it resulted in stronger levels of
brand trust and prescribing.
In our business, the words ‘insight’ and ‘partner’ have become so overused that they
have lost their meaning. In my 20 years of research agency experience, my time as a
member of the GSK Diabetes Hub was unique. No other client has invested in
‘insight’ to the same level, nor engaged me as a ‘partner’ so thoroughly. I felt truly
valued, which motivated me and my team to invest more in GSK Diabetes than we
would normally do for our Key Accounts.
Yours sincerely
Stephen Potts
Regional Lead, Healthcare, Asia, GfK

More Related Content

Similar to Testimonial for Bruce Ratcliffe by Stephen Potts - 21Oct2015

221 Strategies-bio
221 Strategies-bio221 Strategies-bio
221 Strategies-bioMark Santry
 
2010 Bandish Presentation
2010 Bandish Presentation2010 Bandish Presentation
2010 Bandish PresentationJackie Bandish
 
HD Capabilities for Linked in
HD Capabilities for Linked inHD Capabilities for Linked in
HD Capabilities for Linked inKaren Burris
 
boston scientific2003_annual
boston scientific2003_annualboston scientific2003_annual
boston scientific2003_annualfinance28
 
boston scientific2003_annual
boston scientific2003_annualboston scientific2003_annual
boston scientific2003_annualfinance28
 
Holly Whitten Scott - g resume May 2016
Holly Whitten Scott - g resume May 2016Holly Whitten Scott - g resume May 2016
Holly Whitten Scott - g resume May 2016Holly Scott
 
Pharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management AgendaPharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management AgendaSvetlana Pidasheva, PhD, CMPP
 
Matt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationMatt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationTodd Fatone
 
Matt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationMatt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationTodd Fatone
 
Kim_Clinton2017Resume
Kim_Clinton2017ResumeKim_Clinton2017Resume
Kim_Clinton2017ResumeKim Clinton
 
A challenging market to engage - a case study of General Practitioners and an...
A challenging market to engage - a case study of General Practitioners and an...A challenging market to engage - a case study of General Practitioners and an...
A challenging market to engage - a case study of General Practitioners and an...Kai Meischke
 
Most Trusted CRO to Watch in 2023 insightscare.pdf
Most Trusted CRO to Watch in 2023 insightscare.pdfMost Trusted CRO to Watch in 2023 insightscare.pdf
Most Trusted CRO to Watch in 2023 insightscare.pdfinsightscare
 
Final evaluation
Final evaluationFinal evaluation
Final evaluationJamory
 

Similar to Testimonial for Bruce Ratcliffe by Stephen Potts - 21Oct2015 (20)

221 Strategies-bio
221 Strategies-bio221 Strategies-bio
221 Strategies-bio
 
2010 Bandish Presentation
2010 Bandish Presentation2010 Bandish Presentation
2010 Bandish Presentation
 
Trish Bio
Trish BioTrish Bio
Trish Bio
 
HD Capabilities for Linked in
HD Capabilities for Linked inHD Capabilities for Linked in
HD Capabilities for Linked in
 
boston scientific2003_annual
boston scientific2003_annualboston scientific2003_annual
boston scientific2003_annual
 
boston scientific2003_annual
boston scientific2003_annualboston scientific2003_annual
boston scientific2003_annual
 
Holly Whitten Scott - g resume May 2016
Holly Whitten Scott - g resume May 2016Holly Whitten Scott - g resume May 2016
Holly Whitten Scott - g resume May 2016
 
2009-2012 Awards
2009-2012 Awards2009-2012 Awards
2009-2012 Awards
 
Dakota Burrell
Dakota BurrellDakota Burrell
Dakota Burrell
 
Pharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management AgendaPharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management Agenda
 
Brochure v3
Brochure v3Brochure v3
Brochure v3
 
Matt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationMatt Stokes Letter of Recommendation
Matt Stokes Letter of Recommendation
 
Matt Stokes Letter of Recommendation
Matt Stokes Letter of RecommendationMatt Stokes Letter of Recommendation
Matt Stokes Letter of Recommendation
 
Kim_Clinton2017Resume
Kim_Clinton2017ResumeKim_Clinton2017Resume
Kim_Clinton2017Resume
 
A challenging market to engage - a case study of General Practitioners and an...
A challenging market to engage - a case study of General Practitioners and an...A challenging market to engage - a case study of General Practitioners and an...
A challenging market to engage - a case study of General Practitioners and an...
 
Most Trusted CRO to Watch in 2023 insightscare.pdf
Most Trusted CRO to Watch in 2023 insightscare.pdfMost Trusted CRO to Watch in 2023 insightscare.pdf
Most Trusted CRO to Watch in 2023 insightscare.pdf
 
2015 Impact Report
2015 Impact Report2015 Impact Report
2015 Impact Report
 
E4P Sydney Brochure
E4P Sydney BrochureE4P Sydney Brochure
E4P Sydney Brochure
 
Internship Report
Internship ReportInternship Report
Internship Report
 
Final evaluation
Final evaluationFinal evaluation
Final evaluation
 

Testimonial for Bruce Ratcliffe by Stephen Potts - 21Oct2015

  • 1. 86 Taman Nakhoda Villa Delle Rose Singapore 257786 21st October 2015 To Whom It May Concern Re: Testimonial – Bruce Ratcliffe It was my pleasure to work with Bruce Ratcliffe when he was Regional Therapy Area Group Director for Metabolic, Cardiovascular and Urology at GlaxoSmithkline. At the time, I was Head of Healthcare Research for TNS in APAC. In his role, Bruce set up a Regional Diabetes Hub, a cross-functional team including GSK personnel from different disciplines as well as agency representatives from research, PR and communications. This Hub met for 2-3 days, quarterly, and ensured that his agencies were fully informed of the business challenges that GSK were facing and were empowered to recommend activities to create positive change. It also meant that GSK team members were so involved in the insight and communications process that they were able to affect it, ensuring internal buy-in into any outputs that were generated. I first became involved in the Regional Diabetes Hub when Bruce presented TNS with a challenge. After 5 years on the market, GSK’s leading Diabetes brand had still not established itself as the Gold Standard and the Company needed insight into why and what they could do to take the brand to the next level. TNS proposed an innovative methodology involving duos with Specialists, and incorporating a variety of project techniques rarely used in APAC in Healthcare. To Bruce’s credit, he took a risk, recognized the need for an innovative approach and commissioned this groundbreaking research. The ‘killer insights’ that resulted formed the basis for the brand’s sales and marketing initiatives for the next 2 years. In particular, it allowed Bruce to implement Belief Mapping. This involved a process whereby physicians’ current beliefs were understood in depth, through insights research. We then identified the beliefs that we wanted them to hold for GSK’s diabetes portfolio to be successful. And finally, we mapped how to shift their beliefs through a series of steps and initiatives. Bruce championed this approach regionally, the first time that it had been implemented in APAC to my knowledge, and it resulted in stronger levels of brand trust and prescribing. In our business, the words ‘insight’ and ‘partner’ have become so overused that they have lost their meaning. In my 20 years of research agency experience, my time as a member of the GSK Diabetes Hub was unique. No other client has invested in ‘insight’ to the same level, nor engaged me as a ‘partner’ so thoroughly. I felt truly valued, which motivated me and my team to invest more in GSK Diabetes than we would normally do for our Key Accounts. Yours sincerely
  • 2. Stephen Potts Regional Lead, Healthcare, Asia, GfK